Study Information
- PI: Jana de Boniface
- Study supported by EUBREAST
- Trial design: prospective randomized trial to compare full axillary dissection with omission of axillary dissection in patients with 1-2 positive lymph nodes (BCT and mastectomy)
- Primary endpoint: breast cancer specific survival
Publications
Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases – New England Journal of Medicine